BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
LEP
,
calcium channel activity
,
Obesity
,
Leukocyte
,
Anticancer prodrugs
,
Doxycycline
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
B cell antigen receptor
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Plasma membrane topography governs the 3D dynamic localization of IgM B cell antigen receptor cluste…
Structural principles of B cell antigen receptor assembly.
Abelson tyrosine kinase controls BCR signalling and B-cell differentiation by promoting B-cell metab…
B-cell antigen receptor expression and phosphatidylinositol 3-kinase signaling regulate genesis and …
Identification of serine residues in the connexin43 carboxyl tail important for BCR-mediated spreadi…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
T Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell Malignancies
ENABLE (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy…
Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B Cell Malignancies After Fa…
To Observe the Dual-target Chimeric Antigen Receptor T Cells in the Treatment of B Cell Hematologic …
Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Maligna…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ